5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

 

Hematologic Malignancies
06:39

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Frontline Therapy in CLL: Obinutuzumab + Ibrutinib, Ibrutinib vs. Chemoimmunotherapy

FEATURING Ian W. Flinn
  • 119 views
  • March 16, 2021
  • 1
07:09

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

ELEVATE TN Data on Acalabrutinib - Practice Changing Trial in CLL

FEATURING Ian W. Flinn
  • 228 views
  • March 16, 2021
11:47

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Treatment Options for Newly Diagnosed Myeloma: Time to Incorporate CD38 Antibodies?

FEATURING Jesus Berdeja
  • 192 views
  • March 13, 2020
  • 1
09:00

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Treatment Options in R/R Multiple Myeloma: Tips for Selecting Among the Myriad of Choices

FEATURING Jesus Berdeja
  • 639 views
  • March 13, 2020
  • 3
12:36

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Future Directions in Multiple Myeloma: Selinexor Approval, Venetoclax, Belantamab Mafodotin, BCMA:CD3 Bispecifics & CAR T

FEATURING Jesus Berdeja
  • 60 views
  • March 13, 2020
18:23

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Time Limited Therapy in CLL, Ibrutinib vs Zanubrutinib in WM & LOXO-305 in B-cell Malignancies

FEATURING Ian W. Flinn
  • 77 views
  • March 13, 2020